Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Hungary

Research and Innovation Action · Running

FLUniversal Intranasal, rapid-acting vaccine for all seasonal and pandemic influenza viruses

Coordinator
Zafiro Business Solutions Korlatolt Felelossegu Tarsasag, Hungary
Runs
1 June 2023 to 31 May 2027
Status
Running
EU funding
€7.6m
Total cost
€7.6m
Partners
8 organisations in 7 countries
Type
Research and Innovation Action
Grant agreement
101080692

What the project is doing

In the project's own words, from its summary on CORDIS.

Researchers worldwide have been working to develop a universal flu vaccine, but no breakthrough has yet been achieved. FLUniversal is not ""another costly universal flu project"". It is an opportunity to create a genuine universal flu vaccine that will set the standard for rapid, efficient vaccine development, and generate know-how and tools to develop next-generation vaccines. We plan to exploit our increased understanding of molecular mechanisms of influenza infection and immunity to develop a vaccine effective against all flu virus strains.

Our innovation uses genetically modified flu strains administered intranasally in a prime-boost regimen. This approach rapidly induces interferon and broadly cross-neutralising antibodies in the nasal passages and a systemic immune response directed to the conserved HA stalk. Proof of concept for universal protection was demonstrated in the ferret

Topics

Who is involved

OrganisationCityCountryRole
Zafiro Business Solutions Korlatolt Felelossegu TarsasagBudapestHungaryCoordinator
Vivaldi Biosciences AGWienAustriaParticipant
Meditox S.r.oKonaroviceCzechiaParticipant
Statens Serum InstitutKobenhavn SDenmarkParticipant
Vismederi SRLColle Di Val D'Elsa SiItalyParticipant
Academisch Ziekenhuis LeidenLeidenNetherlandsParticipant
Stichting Centre for Human Drug ResearchLeidenNetherlandsParticipant
Medicines and Healthcare Products Regulatory AgencyLondonUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI